Back
Health Catalyst Vs. DXP Enterprises Industry Stock Comparison
Sell
40
HCAT
Health Catalyst
Last Price:
$6.88
Seasonality Move:
-14.04%
Buy
76
DXPE
DXP Enterprises
Last Price:
$91.00
Seasonality Move:
8.05%
Sell
40
Health Catalyst (HCAT)
is a Sell
Is Health Catalyst a Buy, Sell or Hold?
-
The current Health Catalyst [HCAT] share price is $6.89. The Score for HCAT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
HCAT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
-
The current DXP Enterprises [DXPE] share price is $90.99. The Score for DXPE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
DXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HCAT Stock Price Chart
What is Health Catalyst's stock price today?
-
The Health Catalyst share price today is $6.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HCAT is experiencing selling pressure, which indicates risk of future bearish movement.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $90.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing slight buying pressure.
HCAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 39.63 | Sell |
Chaikin Money Flow: | -381942 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.99 - 8.05) | Sell |
Bollinger Bands (100): | (7.25 - 8.43) | Sell |
DXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.55 | Buy |
Relative Strength Index (14 RSI): | 74.58 | Buy |
Chaikin Money Flow: | 7725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (77.39 - 84.31) | Buy |
Bollinger Bands (100): | (49.55 - 75.59) | Buy |
HCAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.18 | Sell |
20-day SMA: | 7.33 | Sell |
50-day SMA: | 7.82 | Sell |
200-day SMA: | 7.21 | Sell |
8-day EMA: | 7.16 | Sell |
20-day EMA: | 7.36 | Sell |
50-day EMA: | 7.64 | Sell |
200-day EMA: | 7.82 | Sell |
DXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 84.32 | Buy |
20-day SMA: | 81.88 | Buy |
50-day SMA: | 73.5 | Buy |
200-day SMA: | 56.32 | Buy |
8-day EMA: | 84.78 | Buy |
20-day EMA: | 81.67 | Buy |
50-day EMA: | 74.38 | Buy |
200-day EMA: | 58 | Buy |
Health Catalyst Earnings Growth & HCAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.21 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.64 per share.
Health Catalyst Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DXP Enterprises Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |